Latest return on equity
Theravance Biopharma Return on equity
Theravance Biopharma (TBPH) return on equity with its verified observation date.
Direct answer
Theravance Biopharma's return on equity is 20.91%.
The verified market snapshot reports 20.91%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked August 23, 2026.
Get free Theravance Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- 20.91%
Explore related company data
View Theravance Biopharma's market capitalizationView Theravance Biopharma's p/e ratioView Theravance Biopharma's price-to-book ratioView Theravance Biopharma's 52-week price rangeView Theravance Biopharma's revenue growthView Theravance Biopharma's profit marginView Theravance Biopharma's debt-to-equity ratioView all Theravance Biopharma key metricsReturn to Theravance Biopharma profile